30 Day Trial

DePuy Synthes Launches SENTIO Nerve Monitoring Technology

Share:

DePuy Synthes introduced SENTIO MMG, a digital mechanomyography platform designed to assess nerve status and identify and avoid peripheral nerves during spine surgery.

Sentio’s platform uses adhesive smart-sensors that are applied to the patient's skin and provide the surgeon with real-time feedback on nerve location. The technology has a minimal footprint in the O.R. and obviates the need for a neuromonitoring specialist in the room. Johnson & Johnson acquired the technology in mid-2017.

Source: DePuy Synthes